Co-injection of ETV-2 and HGF viral vectors significantly improve angiogenesis in mice with hindlimb ischemia

Main Article Content

Phuc Van Pham Ngoc Bich Vu Thuy Thi-Thanh Dao Ha Thi-Ngan Le Lan Thi Phi Ngoc Kim Phan

Abstract

Introduction: Both ETV-2 and HGF factors are known to be important factors which trigger neo-angiogenesis both in vitro and in vivo models. This study aimed to treat hindlimb ischemia in mice by co-injection of ETV-2 and HGF viral vectors.

Methods: ETV-2 and HGF vectors were prepared per previous publications. The mouse ischemic hindlimb model was performed by ligating and burning the artery at the hindlimb. ETV-2 and HGF viral vectors were co-injected into the ligated and burnt sites.

Results: The results showed that co-injection of the vectors significantly improved angiogenesis as well as reduced leg loss in mice compared to placebo treatment. The percentage of mice who succumbed to ischemia was also significantly reduced compared to control.

Conclusion: Overall, this study suggests a potential impact of combining ETV-2 and HGF to treat angiogenesis. Use of ETV-2 and HGF viral vectors can be a promising therapy for ischemia treatment in the future.

References

Ginsberg, M., James, D., Ding, B.S., Nolan, D., Geng, F., Butler, J.M., Schachterle, W., Pulijaal, V.R., Mathew, S., Chasen, S.T., et al. (2012). Efficient direct reprogramming of mature amniotic cells into endothelial cells by ETS factors and TGFbeta suppression. Cell 151, 559-575.
Goto, T., Fukuyama, N., Aki, A., Kanabuchi, K., Kimura, K., Taira, H., Tanaka, E., Wakana, N., Mori, H., and Inoue, H. (2006). Search for appropriate experimental methods to create stable hind-limb ischemia in mouse. The Tokai journal of experimental and clinical medicine 31, 128-132.
Kanda, S., Kanetake, H., and Miyata, Y. (2006). HGF-induced capillary morphogenesis of endothelial cells is regulated by Src. Biochemical and biophysical research communications 344, 617-622.
Kibbe, M.R., Hirsch, A.T., Mendelsohn, F.O., Davies, M.G., Pham, H., Saucedo, J., Marston, W., Pyun, W.B., Min, S.K., Peterson, B.G., et al. (2016). Safety and efficacy of plasmid DNA expressing two isoforms of hepatocyte growth factor in patients with critical limb ischemia. Gene therapy 23, 399.
Lindgren, A.G., Veldman, M.B., and Lin, S. (2015). ETV2 expression increases the efficiency of primitive endothelial cell derivation from human embryonic stem cells. Cell Regeneration 4, 1.
Liu, F., Li, D., Yu, Y.Y.L., Kang, I., Cha, M.J., Kim, J.Y., Park, C., Watson, D.K., Wang, T., and Choi, K. (2015). Induction of hematopoietic and endothelial cell program orchestrated by ETS transcription factor ER71/ETV2. EMBO reports 16, 654-669.
Morita, R., Suzuki, M., Kasahara, H., Shimizu, N., Shichita, T., Sekiya, T., Kimura, A., Sasaki, K., Yasukawa, H., and Yoshimura, A. (2015). ETS transcription factor ETV2 directly converts human fibroblasts into functional endothelial cells. Proceedings of the National Academy of Sciences of the United States of America 112, 160-165.
Park, C., Lee, T.J., Bhang, S.H., Liu, F., Nakamura, R., Oladipupo, S.S., Pitha-Rowe, I., Capoccia, B., Choi, H.S., Kim, T.M., et al. (2016). Injury-Mediated Vascular Regeneration Requires Endothelial ER71/ETV2. Arteriosclerosis, thrombosis, and vascular biology 36, 86-96.
Sulpice, E., Ding, S., Muscatelli-Groux, B., Berge, M., Han, Z.C., Plouet, J., Tobelem, G., and Merkulova-Rainon, T. (2009). Cross-talk between the VEGF-A and HGF signalling pathways in endothelial cells. Biology of the cell 101, 525-539.
Sumanas, S., and Choi, K. (2016). ETS Transcription Factor ETV2/ER71/Etsrp in Hematopoietic and Vascular Development. Current topics in developmental biology 118, 77-111.
Van Pham, P., Vu, N.B., Nguyen, H.T., Dao, T.T.-T., Le, H.T.-N., Phi, L.T., Nguyen, O.T.-K., and Phan, N.K. (2017). ETV-2 activated proliferation of endothelial cells and attenuated acute hindlimb ischemia in mice. In Vitro Cellular & Developmental Biology - Animal.
Van Pham, P., Vu, N.B., Nguyen, H.T., Huynh, O.T., and Truong, M.T.-H. (2016a). Significant improvement of direct reprogramming efficacy of fibroblasts into progenitor endothelial cells by ETV2 and hypoxia. Stem Cell Research & Therapy 7, 104.
Van Pham, P., Vu, N.B., Truong, M.T.-H., Huynh, O.T., Nguyen, H.T., Pham, H.L., and Phan, N.K. (2016b). Hepatocyte growth factor improves direct reprogramming of fibroblasts towards endothelial progenitor cells via ETV2 transduction. Biomedical Research and Therapy 3, 45.
Vu, N.B., Bui, A.N.-T., Ngoc-Le Trinh, V., Phi, L.T., Phan, N.K., and Van Pham, P. (2014). A comparison of umbilical cord blood-derived endothelial progeni-tor and mononuclear cell transplantation for the treatment of acute hindlimb ischemia.
Xin, X., Yang, S., Ingle, G., Zlot, C., Rangell, L., Kowalski, J., Schwall, R., Ferrara, N., and Gerritsen, M.E. (2001). Hepatocyte Growth Factor Enhances Vascular Endothelial Growth Factor-Induced Angiogenesis in Vitro and in Vivo. The American Journal of Pathology 158, 1111-1120.

Downloads

Download data is not yet available.

Article Details

How to Cite
PHAM, Phuc Van et al. Co-injection of ETV-2 and HGF viral vectors significantly improve angiogenesis in mice with hindlimb ischemia. Progress in Stem Cell, [S.l.], v. 4, n. 01, p. 189-200, july 2017. ISSN 2199-4633. Available at: <http://www.cellstemcell.org/index.php/PSC/article/view/193>. Date accessed: 23 oct. 2017. doi: https://doi.org/10.15419/psc.v4i01.193.
Section
Research Articles